The Institute of Biomedical Science (IBMS) has published a response to the government’s newly published ‘Reforming elective care for patients’, saying that investing in diagnostic capacity, digital transformation, and a robust biomedical science workforce is essential to delivering faster, more equitable elective care for all.
The IBMS welcomes the ambitious goals stated in ‘Reforming elective care for patients’ to reduce waiting times, invest in diagnostics, and enhance patient choice and experience. In a statement the Institute commented: “Our members - biomedical scientists and laboratory staff working across pathology and diagnostic services - are fundamental to ensuring these reforms achieve real, tangible benefits for patients.
IBMS Chief Executive David Wells said: “Giving patients rapid access to their test results ensures informed decision-making and strengthens support. However, it’s just as important that these results come with the right professional context and guidance. Biomedical scientists — the experts at the heart of diagnostics — should play a pivotal role in interpreting test data, explaining results clearly, and easing pressure on medics.”
The IBMS statement concludes: “The IBMS welcomes the government’s commitment to improving elective care, particularly the recognition that investment in diagnostics is key to transforming patient experiences and clinical outcomes. Biomedical scientists are integral to making these reforms a success: from designing robust testing pathways and harnessing digital innovations, to interpreting results and helping patients and clinicians alike gain deeper insight into diagnoses.
“We look forward to collaborating with the Department of Health and Social Care, NHS England, and other healthcare professionals to ensure the Plan’s ambitions are delivered safely, efficiently, and equitably for all patients.